Advertisement
Review Article| Volume 41, ISSUE 1, P1-24, March 2020

Lung Cancer 2020

Epidemiology, Etiology, and Prevention

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Chest Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. World Health Organization. Cancer.
        (Available at:) (Accessed 24 November, 2018)
        • Ng M.
        • Freeman M.K.
        • Fleming T.D.
        • et al.
        Smoking prevalence and cigarette consumption in 187 countries, 1980-2012.
        JAMA. 2014; 311: 183-192
        • Dela Cruz C.S.
        • Tanoue L.T.
        • Matthay R.A.
        Lung cancer: epidemiology, etiology, and prevention.
        Clin Chest Med. 2011; 32: 605-644
        • World Health Organization
        Cancer fact sheets, lung cancer.
        (Available at:) (Accessed December 2, 2018)
        • Bray F.
        • Ferlay J.
        • Soerjomataram I.
        • et al.
        Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
        CA Cancer J Clin. 2018; 68: 394-424
        • Torre L.A.
        • Siegel R.L.
        • Jemal A.
        Lung cancer statistics.
        Adv Exp Med Biol. 2016; 893: 1-19
        • Torre L.A.
        • Bray F.
        • Siegel R.L.
        • et al.
        Global cancer statistics, 2012.
        CA Cancer J Clin. 2015; 65: 87-108
        • American Lung Association
        Trends in tobacco use.
        (Available at:) (Accessed November 30, 2018)
        • American Lung Association Research and Program Services
        Trends in tobacco use.
        (Available at:) (Accessed 24 November, 2018)
      2. Howlader N. NA Krapcho M. SEER cancer statistics review, 1975-2016. 2019 (Available at:) (Accessed May 26, 2019)
        • Siegel R.
        • Ward E.
        • Brawley O.
        • et al.
        Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.
        CA Cancer J Clin. 2011; 61: 212-236
        • Siegel R.L.
        • Miller K.D.
        • Jemal A.
        Cancer statistics, 2019.
        CA Cancer J Clin. 2019; 69: 7-34
        • Siegel R.L.
        • Miller K.D.
        • Jemal A.
        Cancer statistics, 2017.
        CA Cancer J Clin. 2017; 67: 7-30
        • Wang T.W.
        • Asman K.
        • Gentzke A.S.
        • et al.
        Tobacco product use among adults - United States, 2017.
        MMWR Morb Mortal Wkly Rep. 2018; 67: 1225-1232
        • Cronin K.A.
        • Lake A.J.
        • Scott S.
        • et al.
        Annual report to the nation on the status of cancer, part I: national cancer statistics.
        Cancer. 2018; 124: 2785-2800
        • Jeon J.
        • Holford T.R.
        • Levy D.T.
        • et al.
        Smoking and lung cancer mortality in the United States from 2015 to 2065: a comparative modeling approach.
        Ann Intern Med. 2018; 169: 684-693
        • Boyer M.J.
        • Williams C.D.
        • Harpole D.H.
        • et al.
        Improved survival of stage I non-small cell lung cancer: a VA Central cancer registry analysis.
        J Thorac Oncol. 2017; 12: 1814-1823
        • Silvestri G.A.
        • Carpenter M.J.
        Smoking trends and lung cancer mortality: the good, the bad, and the ugly.
        Ann Intern Med. 2018; 169: 721-722
        • Aberle D.R.
        • Adams A.M.
        • Berg C.D.
        • et al.
        • National Lung Screening Trial Research Team
        Reduced lung-cancer mortality with low-dose computed tomographic screening.
        N Engl J Med. 2011; 365: 395-409
        • Jemal A.
        • Fedewa S.A.
        Lung cancer screening with low-dose computed tomography in the United States-2010 to 2015.
        JAMA Oncol. 2017; 3: 1278-1281
        • Reck M.
        • Rabe K.F.
        Precision diagnosis and treatment for advanced non-small-cell lung cancer.
        N Engl J Med. 2017; 377: 849-861
        • Donington J.S.
        • Colson Y.L.
        Sex and gender differences in non-small cell lung cancer.
        Semin Thorac Cardiovasc Surg. 2011; 23: 137-145
        • Kligerman S.
        • White C.
        Epidemiology of lung cancer in women: risk factors, survival, and screening.
        AJR Am J Roentgenol. 2011; 196: 287-295
        • Jemal A.
        • Miller K.D.
        • Ma J.
        • et al.
        Higher lung cancer incidence in young women than young men in the United States.
        N Engl J Med. 2018; 378: 1999-2009
        • American Lung Association
        Tobacco use in racial and ethnic populations.
        (Available at:) (Accessed October 28, 2018)
        • Bach P.B.
        • Cramer L.D.
        • Warren J.L.
        • et al.
        Racial differences in the treatment of early-stage lung cancer.
        N Engl J Med. 1999; 341: 1198-1205
        • Hardy D.
        • Liu C.C.
        • Xia R.
        • et al.
        Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer.
        Cancer. 2009; 115: 2199-2211
        • Wisnivesky J.P.
        • McGinn T.
        • Henschke C.
        • et al.
        Ethnic disparities in the treatment of stage I non-small cell lung cancer.
        Am J Respir Crit Care Med. 2005; 171: 1158-1163
        • Tanner N.T.
        • Gebregziabher M.
        • Hughes Halbert C.
        • et al.
        Racial differences in outcomes within the national lung screening trial. Implications for widespread implementation.
        Am J Respir Crit Care Med. 2015; 192: 200-208
        • Ross K.
        • Kramer M.R.
        • Jemal A.
        Geographic inequalities in progress against lung cancer among women in the United States, 1990-2015.
        Cancer Epidemiol Biomarkers Prev. 2018; 27: 1261-1264
        • Jemal A.
        • Ma J.
        • Rosenberg P.S.
        • et al.
        Increasing lung cancer death rates among young women in southern and midwestern States.
        J Clin Oncol. 2012; 30: 2739-2744
        • Jemal A.
        • Thun M.
        • Yu X.Q.
        • et al.
        Changes in smoking prevalence among U.S. Adults by state and region: estimates from the tobacco use supplement to the current population Survey, 1992-2007.
        BMC Public Health. 2011; 11: 512
        • Hastert T.A.
        • Beresford S.A.
        • Sheppard L.
        • et al.
        Disparities in cancer incidence and mortality by area-level socioeconomic status: a multilevel analysis.
        J Epidemiol Community Health. 2015; 69: 168-176
        • Clegg L.X.
        • Reichman M.E.
        • Miller B.A.
        • et al.
        Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: national Longitudinal Mortality Study.
        Cancer Causes Control. 2009; 20: 417-435
        • Sidorchuk A.
        • Agardh E.E.
        • Aremu O.
        • et al.
        Socioeconomic differences in lung cancer incidence: a systematic review and meta-analysis.
        Cancer Causes Control. 2009; 20: 459-471
        • LaPar D.J.
        • Bhamidipati C.M.
        • Harris D.A.
        • et al.
        Gender, race, and socioeconomic status affects outcomes after lung cancer resections in the United States.
        Ann Thorac Surg. 2011; 92: 434-439
        • Hovanec J.
        • Siemiatycki J.
        • Conway D.I.
        • et al.
        Lung cancer and socioeconomic status in a pooled analysis of case-control studies.
        PLoS One. 2018; 13: e0192999
        • Warner K.E.
        • Mendez D.
        Tobacco control policy in developed countries: yesterday, today, and tomorrow.
        Nicotine Tob Res. 2010; 12: 876-887
        • Wynder E.L.
        • Graham E.A.
        Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases.
        J Am Med Assoc. 1950; 143: 329-336
        • U.S. Public Health Service, Office of the Surgeon General: the health consequences of smoking
        72-7516 PNH.
        National Clearinghouse for Smoking Health., Washington, DC1972
        • Adler I.
        Primary malignant growth of the lung and bronchi.
        Longman, Green, Company., New York1912
        • Pear R.
        Tobacco smoking and longevity.
        Science. 1938; 87: 216
        • Ochsner A.
        • DeBakey M.
        Primary pulmonary malignancy: treatment of total pneumonectomy. Analysis of seventy-nine collected cases and presentation of seven personal cases.
        Surg Gynecol Obstet. 1939; 68: 435
        • Doll R.
        • Hill A.B.
        Smoking and carcinoma of the lung; preliminary report.
        Br Med J. 1950; 2: 739-748
        • Wynder E.L.
        • Graham E.A.
        Etiologic factors in bronchiogenic carcinoma with special reference to industrial exposures; report of eight hundred fifty-seven proved cases.
        AMA Arch Ind Hyg Occup Med. 1951; 4: 221-235
        • US Department of Health
        • Education
        • and Welfare
        Smoking and health report of the advisory committee to the surgeon general of the public health service.
        US Department of Health, Education, and Welfare, Public Health Service, Washington1964 (PHS Publication No. 1103)
        • US Department of Health and Human Services
        The health consequences of smoking: 50 Years of progress. A report of the surgeon general.
        US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta (GA)2014
        • Hoffmann D.
        • Hoffmann I.
        The changing cigarette, 1950-1995.
        J Toxicol Environ Health. 1997; 50: 307-364
        • Smith C.J.
        • Perfetti T.A.
        • Mullens M.A.
        • et al.
        "IARC group 2B Carcinogens" reported in cigarette mainstream smoke.
        Food Chem Toxicol. 2000; 38: 825-848
        • Akopyan G.
        • Bonavida B.
        Understanding tobacco smoke carcinogen NNK and lung tumorigenesis.
        Int J Oncol. 2006; 29: 745-752
        • Wynder E.L.
        • Hoffmann D.
        Smoking and lung cancer: scientific challenges and opportunities.
        Cancer Res. 1994; 54: 5284-5295
        • Harris J.E.
        • Thun M.J.
        • Mondul A.M.
        • et al.
        Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-8.
        BMJ. 2004; 328: 72
        • Pisani P.
        • Bray F.
        • Parkin D.M.
        Estimates of the world-wide prevalence of cancer for 25 sites in the adult population.
        Int J Cancer. 2002; 97: 72-81
        • Babb S.
        • Malarcher A.
        • Schauer G.
        • et al.
        Quitting smoking among adults - United States, 2000-2015.
        MMWR Morb Mortal Wkly Rep. 2017; 65: 1457-1464
        • Johnson K.C.
        • Hu J.
        • Mao Y.
        • et al.
        Lifetime residential and workplace exposure to environmental tobacco smoke and lung cancer in never-smoking women, Canada 1994-97.
        Int J Cancer. 2001; 93: 902-906
        • Lee C.H.
        • Ko Y.C.
        • Goggins W.
        • et al.
        Lifetime environmental exposure to tobacco smoke and primary lung cancer of non-smoking Taiwanese women.
        Int J Epidemiol. 2000; 29: 224-231
        • Kim A.S.
        • Ko H.J.
        • Kwon J.H.
        • et al.
        Exposure to secondhand smoke and risk of cancer in never smokers: a meta-analysis of epidemiologic studies.
        Int J Environ Res Public Health. 2018; 15 ([pii:E1981])
        • Janerich D.T.
        • Thompson W.D.
        • Varela L.R.
        • et al.
        Lung cancer and exposure to tobacco smoke in the household.
        N Engl J Med. 1990; 323: 632-636
        • Hackshaw A.K.
        • Law M.R.
        • Wald N.J.
        The accumulated evidence on lung cancer and environmental tobacco smoke.
        BMJ. 1997; 315: 980-988
        • Cardenas V.M.
        • Thun M.J.
        • Austin H.
        • et al.
        Environmental tobacco smoke and lung cancer mortality in the American Cancer Society's Cancer Prevention Study. II.
        Cancer Causes Control. 1997; 8: 57-64
        • Hecht S.S.
        • Carmella S.G.
        • Murphy S.E.
        • et al.
        A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke.
        N Engl J Med. 1993; 329: 1543-1546
        • Pirkle J.L.
        • Flegal K.M.
        • Bernert J.T.
        • et al.
        Exposure of the US population to environmental tobacco smoke: the third national health and Nutrition Examination Survey, 1988 to 1991.
        JAMA. 1996; 275: 1233-1240
        • Jemal A.
        • Bray F.
        • Center M.M.
        • et al.
        Global cancer statistics.
        CA Cancer J Clin. 2011; 61: 69-90
        • Jha P.
        • Ramasundarahettige C.
        • Landsman V.
        • et al.
        21st-century hazards of smoking and benefits of cessation in the United States.
        N Engl J Med. 2013; 368: 341-350
        • Dinakar C.
        • O'Connor G.T.
        The health effects of electronic cigarettes.
        N Engl J Med. 2016; 375: 1372-1381
        • Meo S.A.
        • Al Asiri S.A.
        Effects of electronic cigarette smoking on human health.
        Eur Rev Med Pharmacol Sci. 2014; 18: 3315-3319
        • Schraufnagel D.E.
        • Blasi F.
        • Drummond M.B.
        • et al.
        Electronic cigarettes. A position statement of the forum of international respiratory societies.
        Am J Respir Crit Care Med. 2014; 190: 611-618
        • Schoenborn C.A.
        • Gindi R.M.
        Electronic cigarette use among adults: United States, 2014.
        NCHS Data Brief. 2015; : 1-8
        • Jamal A.
        • Gentzke A.
        • Hu S.S.
        • et al.
        Tobacco use among middle and high school students-United States, 2011-2016.
        MMWR-Morbid Mortal W. 2017; 66: 597-603
        • Soneji S.
        • Barrington-Trimis J.L.
        • Wills T.A.
        • et al.
        Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis.
        JAMA Pediatr. 2017; 171: 788-797
        • Tegin G.
        • Mekala H.M.
        • Sarai S.K.
        • et al.
        E-cigarette toxicity?.
        South Med J. 2018; 111: 35-38
        • Ramo D.E.
        • Liu H.
        • Prochaska J.J.
        Tobacco and marijuana use among adolescents and young adults: a systematic review of their co-use.
        Clin Psychol Rev. 2012; 32: 105-121
        • Volkow N.D.
        • Baler R.D.
        • Compton W.M.
        • et al.
        Adverse health effects of marijuana use.
        N Engl J Med. 2014; 370: 2219-2227
        • Barsky S.H.
        • Roth M.D.
        • Kleerup E.C.
        • et al.
        Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco.
        J Natl Cancer Inst. 1998; 90: 1198-1205
        • Aldington S.
        • Harwood M.
        • Cox B.
        • et al.
        Cannabis use and risk of lung cancer: a case-control study.
        Eur Respir J. 2008; 31: 280-286
        • Tashkin D.P.
        Effects of marijuana smoking on the lung.
        Ann Am Thorac Soc. 2013; 10: 239-247
        • Huang Y.H.
        • Zhang Z.F.
        • Tashkin D.P.
        • et al.
        An epidemiologic review of marijuana and cancer: an update.
        Cancer Epidemiol Biomarkers Prev. 2015; 24: 15-31
        • Parkin D.M.
        • Bray F.
        • Ferlay J.
        • et al.
        Global cancer statistics, 2002.
        CA Cancer J Clin. 2005; 55: 74-108
        • Wakelee H.A.
        • Chang E.T.
        • Gomez S.L.
        • et al.
        Lung cancer incidence in never smokers.
        J Clin Oncol. 2007; 25: 472-478
        • Sun S.
        • Schiller J.H.
        • Gazdar A.F.
        Lung cancer in never smokers–a different disease.
        Nat Rev Cancer. 2007; 7: 778-790
        • Pelosof L.
        • Ahn C.
        • Gao A.
        • et al.
        Proportion of never-smoker non-small cell lung cancer patients at three diverse institutions.
        J Natl Cancer Inst. 2017; 109
        • Bonjour S.
        • Adair-Rohani H.
        • Wolf J.
        • et al.
        Solid fuel use for household cooking: country and regional estimates for 1980-2010.
        Environ Health Perspect. 2013; 121: 784-790
        • Luo R.X.
        • Wu B.
        • Yi Y.N.
        • et al.
        Indoor burning coal air pollution and lung cancer–a case-control study in Fuzhou, China.
        Lung Cancer. 1996; 14: S113-S119
        • Kleinerman R.A.
        • Wang Z.
        • Wang L.
        • et al.
        Lung cancer and indoor exposure to coal and biomass in rural China.
        J Occup Environ Med. 2002; 44: 338-344
        • Hosgood H.D.
        • Boffetta P.
        • Greenland S.
        • et al.
        In-home coal and wood use and lung cancer risk: a pooled analysis of the International Lung Cancer Consortium.
        Environ Health Perspect. 2010; 118: 1743-1747
        • Li J.
        • Li W.X.
        • Bai C.
        • et al.
        Particulate matter-induced epigenetic changes and lung cancer.
        Clin Respir J. 2017; 11: 539-546
        • Pershagen G.
        Air pollution and cancer.
        IARC Sci Publ. 1990; : 240-251
        • Dockery D.W.
        • Pope C.A.
        • Xu X.
        • et al.
        An association between air pollution and mortality in six U.S. cities.
        N Engl J Med. 1993; 329: 1753-1759
        • Pope C.A.
        • Burnett R.T.
        • Thun M.J.
        • et al.
        Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution.
        JAMA. 2002; 287: 1132-1141
        • Cohen A.J.
        • Brauer M.
        • Burnett R.
        • et al.
        Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015.
        Lancet. 2017; 389: 1907-1918
        • Lipsett M.
        • Campleman S.
        Occupational exposure to diesel exhaust and lung cancer: a meta-analysis.
        Am J Public Health. 1999; 89: 1009-1017
        • Raaschou-Nielsen O.
        • Pedersen M.
        • Stafoggia M.
        • et al.
        Outdoor air pollution and risk for kidney parenchyma cancer in 14 European cohorts.
        Int J Cancer. 2017; 140: 1528-1537
        • Raaschou-Nielsen O.
        • Beelen R.
        • Wang M.
        • et al.
        Particulate matter air pollution components and risk for lung cancer.
        Environ Int. 2016; 87: 66-73
        • Samet J.M.
        Residential radon and lung cancer: end of the story?.
        J Toxicol Environ Health A. 2006; 69: 527-531
        • Lubin J.H.
        • Boice J.D.
        • Edling C.
        • et al.
        Lung cancer in radon-exposed miners and estimation of risk from indoor exposure.
        J Natl Cancer Inst. 1995; 87: 817-827
        • Saccomanno G.
        • Huth G.C.
        • Auerbach O.
        • et al.
        Relationship of radioactive radon daughters and cigarette smoking in the genesis of lung cancer in uranium miners.
        Cancer. 1988; 62: 1402-1408
        • Fabrikant J.I.
        Radon and lung cancer: the BEIR IV Report.
        Health Phys. 1990; 59: 89-97
        • Lubin J.H.
        • Boice J.D.
        Lung cancer risk from residential radon: meta-analysis of eight epidemiologic studies.
        J Natl Cancer Inst. 1997; 89: 49-57
        • Ajrouche R.
        • Ielsch G.
        • Cléro E.
        • et al.
        Quantitative health risk assessment of indoor radon: a systematic review.
        Radiat Prot Dosimetry. 2017; 177: 69-77
        • Fingerhut M.
        • Nelson D.I.
        • Driscoll T.
        • et al.
        The contribution of occupational risks to the global burden of disease: summary and next steps.
        Med Lav. 2006; 97: 313-321
        • Steenland K.
        • Burnett C.
        • Lalich N.
        • et al.
        Dying for work: the magnitude of US mortality from selected causes of death associated with occupation.
        Am J Ind Med. 2003; 43: 461-482
        • Jones R.N.
        • Hughes J.M.
        • Weill H.
        Asbestos exposure, asbestosis, and asbestos-attributable lung cancer.
        Thorax. 1996; 51: S9-S15
        • Egilman D.
        • Reinert A.
        Lung cancer and asbestos exposure: asbestosis is not necessary.
        Am J Ind Med. 1996; 30: 398-406
        • Weiss W.
        Asbestosis: a marker for the increased risk of lung cancer among workers exposed to asbestos.
        Chest. 1999; 115: 536-549
        • Syrjänen K.J.
        Bronchial squamous cell carcinomas associated with epithelial changes identical to condylomatous lesions of the uterine cervix.
        Lung. 1980; 158: 131-142
        • Nielsen L.S.
        • Bælum J.
        • Rasmussen J.
        • et al.
        Occupational asbestos exposure and lung cancer–a systematic review of the literature.
        Arch Environ Occup Health. 2014; 69: 191-206
        • United States Department of Labor
        Occupational safety and health administration.
        (Available at:) (Accessed January 6, 2019)
        • World Health Organization
        Radon and health.
        (Available at:) (Accessed January 6, 2019)
        • World Health Organization
        Air pollution.
        (Available at:) (Accessed January 6, 2019)
        • Spitz M.R.
        • Etzel C.J.
        • Dong Q.
        • et al.
        An expanded risk prediction model for lung cancer.
        Cancer Prev Res (Phila). 2008; 1: 250-254
        • Cassidy A.
        • Myles J.P.
        • van Tongeren M.
        • et al.
        The LLP risk model: an individual risk prediction model for lung cancer.
        Br J Cancer. 2008; 98: 270-276
        • Matakidou A.
        • Eisen T.
        • Houlston R.S.
        Systematic review of the relationship between family history and lung cancer risk.
        Br J Cancer. 2005; 93: 825-833
        • Wang Y.
        • McKay J.D.
        • Rafnar T.
        • et al.
        Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.
        Nat Genet. 2014; 46: 736-741
        • Wang J.
        • Liu Q.
        • Yuan S.
        • et al.
        Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies.
        Sci Rep. 2017; 7: 8371
        • McKay J.D.
        • Hung R.J.
        • Han Y.
        • et al.
        Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.
        Nat Genet. 2017; 49: 1126-1132
        • Velmurugan K.R.
        • Varghese R.T.
        • Fonville N.C.
        • et al.
        High-depth, high-accuracy microsatellite genotyping enables precision lung cancer risk classification.
        Oncogene. 2017; 36: 6383-6390
        • Spitz M.R.
        • Wei Q.
        • Dong Q.
        • et al.
        Genetic susceptibility to lung cancer: the role of DNA damage and repair.
        Cancer Epidemiol Biomarkers Prev. 2003; 12: 689-698
        • Turner M.C.
        • Chen Y.
        • Krewski D.
        • et al.
        Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers.
        Am J Respir Crit Care Med. 2007; 176: 285-290
        • Siemes C.
        • Visser L.E.
        • Coebergh J.W.
        • et al.
        C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
        J Clin Oncol. 2006; 24: 5216-5222
        • Parimon T.
        • Chien J.W.
        • Bryson C.L.
        • et al.
        Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease.
        Am J Respir Crit Care Med. 2007; 175: 712-719
        • Raymakers A.J.N.
        • Sadatsafavi M.
        • Sin D.D.
        • et al.
        Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study.
        Eur Respir J. 2019; 53 ([pii:1801257])
        • Wu M.F.
        • Jian Z.H.
        • Huang J.Y.
        • et al.
        Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD.
        BMC Cancer. 2016; 16: 778
        • Yang P.
        • Sun Z.
        • Krowka M.J.
        • et al.
        Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk.
        Arch Intern Med. 2008; 168: 1097-1103
        • Hubbard R.
        • Venn A.
        • Lewis S.
        • et al.
        Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.
        Am J Respir Crit Care Med. 2000; 161: 5-8
        • Antoniou K.M.
        • Tomassetti S.
        • Tsitoura E.
        • et al.
        Idiopathic pulmonary fibrosis and lung cancer: a clinical and pathogenesis update.
        Curr Opin Pulm Med. 2015; 21: 626-633
        • de Freitas A.C.
        • Gurgel A.P.
        • de Lima E.G.
        • et al.
        Human papillomavirus and lung carcinogenesis: an overview.
        J Cancer Res Clin Oncol. 2016; 142: 2415-2427
        • Willey J.C.
        • Broussoud A.
        • Sleemi A.
        • et al.
        Immortalization of normal human bronchial epithelial cells by human papillomaviruses 16 or 18.
        Cancer Res. 1991; 51: 5370-5377
        • Cao S.
        • Wendl M.C.
        • Wyczalkowski M.A.
        • et al.
        Divergent viral presentation among human tumors and adjacent normal tissues.
        Sci Rep. 2016; 6: 28294
        • Castro C.Y.
        • Ostrowski M.L.
        • Barrios R.
        • et al.
        Relationship between Epstein-Barr virus and lymphoepithelioma-like carcinoma of the lung: a clinicopathologic study of 6 cases and review of the literature.
        Hum Pathol. 2001; 32: 863-872
        • Bando M.
        • Takahashi M.
        • Ohno S.
        • et al.
        Torque teno virus DNA titre elevated in idiopathic pulmonary fibrosis with primary lung cancer.
        Respirology. 2008; 13: 263-269
        • Giuliani L.
        • Jaxmar T.
        • Casadio C.
        • et al.
        Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma.
        Lung Cancer. 2007; 57: 273-281
        • Sion-Vardy N.
        • Lasarov I.
        • Delgado B.
        • et al.
        Measles virus: evidence for association with lung cancer.
        Exp Lung Res. 2009; 35: 701-712
        • Littman A.J.
        • Jackson L.A.
        • Vaughan T.L.
        Chlamydia pneumoniae and lung cancer: epidemiologic evidence.
        Cancer Epidemiol Biomarkers Prev. 2005; 14: 773-778
        • Khan S.
        • Imran A.
        • Khan A.A.
        • et al.
        Systems Biology approaches for the prediction of possible role of Chlamydia pneumoniae proteins in the etiology of lung cancer.
        PLoS One. 2016; 11: e0148530
        • Yu Y.H.
        • Liao C.C.
        • Hsu W.H.
        • et al.
        Increased lung cancer risk among patients with pulmonary tuberculosis: a population cohort study.
        J Thorac Oncol. 2011; 6: 32-37
        • Hong S.
        • Mok Y.
        • Jeon C.
        • et al.
        Tuberculosis, smoking and risk for lung cancer incidence and mortality.
        Int J Cancer. 2016; 139: 2447-2455
        • Engels E.A.
        • Shen M.
        • Chapman R.S.
        • et al.
        Tuberculosis and subsequent risk of lung cancer in Xuanwei, China.
        Int J Cancer. 2009; 124: 1183-1187
        • Morris A.
        • Crothers K.
        • Beck J.M.
        • et al.
        An official ATS workshop report: emerging issues and current controversies in HIV-associated pulmonary diseases.
        Proc Am Thorac Soc. 2011; 8: 17-26
        • Reddy K.P.
        • Kong C.Y.
        • Hyle E.P.
        • et al.
        Lung cancer mortality associated with smoking and smoking cessation among people living with HIV in the United States.
        JAMA Intern Med. 2017; 177: 1613-1621
        • Sigel K.
        • Wisnivesky J.
        • Gordon K.
        • et al.
        HIV as an independent risk factor for incident lung cancer.
        AIDS. 2012; 26: 1017-1025
        • Kirk G.D.
        • Merlo C.
        • O' Driscoll P.
        • et al.
        HIV infection is associated with an increased risk for lung cancer, independent of smoking.
        Clin Infect Dis. 2007; 45: 103-110
        • Sigel K.
        • Wisnivesky J.
        • Crothers K.
        • et al.
        Immunological and infectious risk factors for lung cancer in US veterans with HIV: a longitudinal cohort study.
        Lancet HIV. 2017; 4: e67-e73
        • Mitsuyasu R.T.
        Non–AIDS-defining malignancies in HIV.
        Top HIV Med. 2008; 16: 117-121
        • Mao Q.
        • Jiang F.
        • Yin R.
        • et al.
        Interplay between the lung microbiome and lung cancer.
        Cancer Lett. 2018; 415: 40-48
        • Tsay J.J.
        • Wu B.G.
        • Badri M.H.
        • et al.
        Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer.
        Am J Respir Crit Care Med. 2018; 198: 1188-1198
        • Gnagnarella P.
        • Caini S.
        • Maisonneuve P.
        • et al.
        Carcinogenicity of high consumption of meat and lung cancer risk among non-smokers: a comprehensive meta-analysis.
        Nutr Cancer. 2018; 70: 1-13
        • Jacobs E.J.
        • Newton C.C.
        • Thun M.J.
        • et al.
        Long-term use of cholesterol-lowering drugs and cancer incidence in a large United States cohort.
        Cancer Res. 2011; 71: 1763-1771
        • Hecht S.S.
        Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis.
        Proc Soc Exp Biol Med. 1997; 216: 181-191
        • Boone C.W.
        • Kelloff G.J.
        • Malone W.E.
        Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review.
        Cancer Res. 1990; 50: 2-9
        • Goodman G.E.
        • Thornquist M.D.
        • Balmes J.
        • et al.
        The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.
        J Natl Cancer Inst. 2004; 96: 1743-1750
        • Wright M.E.
        • Park Y.
        • Subar A.F.
        • et al.
        Intakes of fruit, vegetables, and specific botanical groups in relation to lung cancer risk in the NIH-AARP Diet and Health Study.
        Am J Epidemiol. 2008; 168: 1024-1034
        • Buring J.E.
        • Hennekens C.H.
        beta-carotene and cancer chemoprevention.
        J Cell Biochem Suppl. 1995; 22: 226-230
        • Yong L.C.
        • Brown C.C.
        • Schatzkin A.
        • et al.
        Intake of vitamins E, C, and A and risk of lung cancer. The NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey.
        Am J Epidemiol. 1997; 146: 231-243
        • Omenn G.S.
        • Goodman G.E.
        • Thornquist M.D.
        • et al.
        Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease.
        N Engl J Med. 1996; 334: 1150-1155
        • Mahabir S.
        • Spitz M.R.
        • Barrera S.L.
        • et al.
        Dietary zinc, copper and selenium, and risk of lung cancer.
        Int J Cancer. 2007; 120: 1108-1115
        • Mahabir S.
        • Forman M.R.
        • Dong Y.Q.
        • et al.
        Mineral intake and lung cancer risk in the NIH-American association of retired persons diet and health study.
        Cancer Epidemiol Biomarkers Prev. 2010; 19: 1976-1983
        • Vieira A.R.
        • Abar L.
        • Vingeliene S.
        • et al.
        Fruits, vegetables and lung cancer risk: a systematic review and meta-analysis.
        Ann Oncol. 2016; 27: 81-96
        • Wang M.
        • Qin S.
        • Zhang T.
        • et al.
        The effect of fruit and vegetable intake on the development of lung cancer: a meta-analysis of 32 publications and 20,414 cases.
        Eur J Clin Nutr. 2015; 69: 1184-1192
        • Brennan P.
        • Hsu C.C.
        • Moullan N.
        • et al.
        Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach.
        Lancet. 2005; 366: 1558-1560
        • Fontham E.T.
        Protective dietary factors and lung cancer.
        Int J Epidemiol. 1990; 19: S32-S42
        • Cooper D.A.
        • Eldridge A.L.
        • Peters J.C.
        Dietary carotenoids and lung cancer: a review of recent research.
        Nutr Rev. 1999; 57: 133-145
        • Mursu J.
        • Nurmi T.
        • Tuomainen T.P.
        • et al.
        Intake of flavonoids and risk of cancer in Finnish men: the Kuopio Ischaemic heart disease risk factor study.
        Int J Cancer. 2008; 123: 660-663
        • Brenner D.R.
        • Fehringer G.
        • Zhang Z.F.
        • et al.
        Alcohol consumption and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium and the SYNERGY study.
        Cancer Epidemiol. 2019; 58: 25-32
        • Fehringer G.
        • Brenner D.R.
        • Zhang Z.F.
        • et al.
        Alcohol and lung cancer risk among never smokers: a pooled analysis from the international lung cancer consortium and the SYNERGY study.
        Int J Cancer. 2017; 140: 1976-1984
        • Xie Y.
        • Qin J.
        • Nan G.
        • et al.
        Coffee consumption and the risk of lung cancer: an updated meta-analysis of epidemiological studies.
        Eur J Clin Nutr. 2016; 70: 199-206
        • Renehan A.G.
        • Tyson M.
        • Egger M.
        • et al.
        Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.
        Lancet. 2008; 371: 569-578
        • Renehan A.G.
        • Soerjomataram I.
        • Leitzmann M.F.
        Interpreting the epidemiological evidence linking obesity and cancer: a framework for population-attributable risk estimations in Europe.
        Eur J Cancer. 2010; 46: 2581-2592
        • Zhu H.
        • Zhang S.
        Body mass index and lung cancer risk in never smokers: a meta-analysis.
        BMC Cancer. 2018; 18: 635
        • Patel A.V.
        • Carter B.D.
        • Stevens V.L.
        • et al.
        The relationship between physical activity, obesity, and lung cancer risk by smoking status in a large prospective cohort of US adults.
        Cancer Causes Control. 2017; 28: 1357-1368
        • Kabat G.C.
        • Kim M.
        • Hunt J.R.
        • et al.
        Body mass index and waist circumference in relation to lung cancer risk in the Women's Health Initiative.
        Am J Epidemiol. 2008; 168: 158-169
        • Friedenreich C.M.
        • Orenstein M.R.
        Physical activity and cancer prevention: etiologic evidence and biological mechanisms.
        J Nutr. 2002; 132: 3456S-3464S
        • Pletnikoff P.P.
        • Tuomainen T.P.
        • Laukkanen J.A.
        • et al.
        Cardiorespiratory fitness and lung cancer risk: a prospective population-based cohort study.
        J Sci Med Sport. 2016; 19: 98-102
        • Laukkanen J.A.
        • Pukkala E.
        • Rauramaa R.
        • et al.
        Cardiorespiratory fitness, lifestyle factors and cancer risk and mortality in Finnish men.
        Eur J Cancer. 2010; 46: 355-363
        • Katki H.A.
        • Kovalchik S.A.
        • Petito L.C.
        • et al.
        Implications of nine risk prediction models for selecting ever-smokers for computed tomography lung cancer screening.
        Ann Intern Med. 2018; 169: 10-19
        • Tammemagi M.C.
        • Katki H.A.
        • Hocking W.G.
        • et al.
        Selection criteria for lung-cancer screening.
        N Engl J Med. 2013; 368: 728-736
        • Katki H.A.
        • Kovalchik S.A.
        • Berg C.D.
        • et al.
        Development and validation of risk models to select ever-smokers for CT lung cancer screening.
        JAMA. 2016; 315: 2300-2311
        • Tammemagi M.C.
        Selecting lung cancer screenees using risk prediction models-where do we go from here.
        Transl Lung Cancer Res. 2018; 7: 243-253
        • Szabo E.
        • Mao J.T.
        • Lam S.
        • et al.
        Chemoprevention of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
        Chest. 2013; 143: e40S-e60S
        • Khurana V.
        • Bejjanki H.R.
        • Caldito G.
        • et al.
        Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans.
        Chest. 2007; 131: 1282-1288
        • Sorli K.
        • Thorvaldsen S.M.
        • Hatlen P.
        Use of inhaled corticosteroids and the risk of lung cancer, the HUNT study.
        Lung. 2018; 196: 179-184